A citation-based method for searching scientific literature

Markus F Neurath. Nat Rev Immunol 2014
Times Cited: 1154







List of co-cited articles
500 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Ulcerative colitis.
Ryan Ungaro, Saurabh Mehandru, Patrick B Allen, Laurent Peyrin-Biroulet, Jean-Frédéric Colombel. Lancet 2017
875
8

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.
Luke Jostins, Stephan Ripke, Rinse K Weersma, Richard H Duerr, Dermot P McGovern, Ken Y Hui, James C Lee, L Philip Schumm, Yashoda Sharma, Carl A Anderson,[...]. Nature 2012
8

Immunopathogenesis of IBD: current state of the art.
Heitor S P de Souza, Claudio Fiocchi. Nat Rev Gastroenterol Hepatol 2016
611
7

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
Siew C Ng, Hai Yun Shi, Nima Hamidi, Fox E Underwood, Whitney Tang, Eric I Benchimol, Remo Panaccione, Subrata Ghosh, Justin C Y Wu, Francis K L Chan,[...]. Lancet 2017
6

Inflammatory bowel disease: pathogenesis.
Yi-Zhen Zhang, Yong-Yu Li. World J Gastroenterol 2014
426
6

Interferon Lambda Promotes Paneth Cell Death Via STAT1 Signaling in Mice and Is Increased in Inflamed Ileal Tissues of Patients With Crohn's Disease.
Claudia Günther, Barbara Ruder, Iris Stolzer, Heidrun Dorner, Gui-Wei He, Mircea Teodor Chiriac, Konrad Aden, Anne Strigli, Miriam Bittel, Sebastian Zeissig,[...]. Gastroenterology 2019
30
20


Genetics and pathogenesis of inflammatory bowel disease.
Bernard Khor, Agnès Gardet, Ramnik J Xavier. Nature 2011
6

Ulcerative colitis.
Ingrid Ordás, Lars Eckmann, Mark Talamini, Daniel C Baumgart, William J Sandborn. Lancet 2012
871
6



Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
William J Sandborn, Chinyu Su, Bruce E Sands, Geert R D'Haens, Séverine Vermeire, Stefan Schreiber, Silvio Danese, Brian G Feagan, Walter Reinisch, Wojciech Niezychowski,[...]. N Engl J Med 2017
565
5

Ulcerative colitis.
Silvio Danese, Claudio Fiocchi. N Engl J Med 2011
717
5

Chemically induced mouse models of acute and chronic intestinal inflammation.
Stefan Wirtz, Vanessa Popp, Markus Kindermann, Katharina Gerlach, Benno Weigmann, Stefan Fichtner-Feigl, Markus F Neurath. Nat Protoc 2017
356
5

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu'Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger,[...]. Gut 2019
394
5

JAK-STAT pathway targeting for the treatment of inflammatory bowel disease.
Azucena Salas, Cristian Hernandez-Rocha, Marjolijn Duijvestein, William Faubion, Dermot McGovern, Severine Vermeire, Stefania Vetrano, Niels Vande Casteele. Nat Rev Gastroenterol Hepatol 2020
85
5

Crohn's disease.
Daniel C Baumgart, William J Sandborn. Lancet 2012
5

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Stephen B Hanauer, Brian G Feagan, Gary R Lichtenstein, Lloyd F Mayer, S Schreiber, Jean Frederic Colombel, Daniel Rachmilewitz, Douglas C Wolf, Allan Olson, Weihang Bao,[...]. Lancet 2002
4

Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease.
Heike Schmitt, Ulrike Billmeier, Walburga Dieterich, Timo Rath, Sophia Sonnewald, Stephen Reid, Simon Hirschmann, Kai Hildner, Maximilian J Waldner, Jonas Mudter,[...]. Gut 2019
58
6

The global burden of IBD: from 2015 to 2025.
Gilaad G Kaplan. Nat Rev Gastroenterol Hepatol 2015
787
4

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Brian G Feagan, William J Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Joshua R Friedman, Marion A Blank, Jewel Johanns, Long-Long Gao, Ye Miao,[...]. N Engl J Med 2016
724
4

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.
Wolfgang Hueber, Bruce E Sands, Steve Lewitzky, Marc Vandemeulebroecke, Walter Reinisch, Peter D R Higgins, Jan Wehkamp, Brian G Feagan, Michael D Yao, Marek Karczewski,[...]. Gut 2012
901
4

Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD.
Marco Daperno, Geert D'Haens, Gert Van Assche, Filip Baert, Philippe Bulois, Vincent Maunoury, Raffaello Sostegni, Rodolfo Rocca, Angelo Pera, Annemie Gevers,[...]. Gastrointest Endosc 2004
841
4

Janus kinases in immune cell signaling.
Kamran Ghoreschi, Arian Laurence, John J O'Shea. Immunol Rev 2009
657
4


Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials.
Julian Panés, William J Sandborn, Stefan Schreiber, Bruce E Sands, Séverine Vermeire, Geert D'Haens, Remo Panaccione, Peter D R Higgins, Jean-Frederic Colombel, Brian G Feagan,[...]. Gut 2017
173
4

Crohn's disease.
Joana Torres, Saurabh Mehandru, Jean-Frédéric Colombel, Laurent Peyrin-Biroulet. Lancet 2017
633
4

Interferon-gamma: an overview of signals, mechanisms and functions.
Kate Schroder, Paul J Hertzog, Timothy Ravasi, David A Hume. J Leukoc Biol 2004
4

The biology of innate lymphoid cells.
David Artis, Hergen Spits. Nature 2015
858
4

Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors.
C C Bain, C L Scott, H Uronen-Hansson, S Gudjonsson, O Jansson, O Grip, M Guilliams, B Malissen, W W Agace, A McI Mowat. Mucosal Immunol 2013
507
4

Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells.
Ehud Zigmond, Chen Varol, Julia Farache, Elinor Elmaliah, Ansuman T Satpathy, Gilgi Friedlander, Matthias Mack, Nahum Shpigel, Ivo G Boneca, Kenneth M Murphy,[...]. Immunity 2012
444
4

Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa.
G Rogler, K Brand, D Vogl, S Page, R Hofmeister, T Andus, R Knuechel, P A Baeuerle, J Schölmerich, V Gross. Gastroenterology 1998
544
4

NF-kappaB in inflammatory bowel disease.
I Atreya, R Atreya, M F Neurath. J Intern Med 2008
448
4

Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease.
Matthias Friedrich, Mathilde Pohin, Fiona Powrie. Immunity 2019
136
4

Environmental triggers in IBD: a review of progress and evidence.
Ashwin N Ananthakrishnan, Charles N Bernstein, Dimitrios Iliopoulos, Andrew Macpherson, Markus F Neurath, Raja A Raja Ali, Stephan R Vavricka, Claudio Fiocchi. Nat Rev Gastroenterol Hepatol 2018
232
4

Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances.
Sebastian Zundler, Emily Becker, Lisa Lou Schulze, Markus F Neurath. Gut 2019
40
10

Leukocyte Trafficking to the Small Intestine and Colon.
Aida Habtezion, Linh P Nguyen, Husein Hadeiba, Eugene C Butcher. Gastroenterology 2016
151
4

Inflammatory bowel disease.
Arthur Kaser, Sebastian Zeissig, Richard S Blumberg. Annu Rev Immunol 2010
4

Induction of intestinal Th17 cells by segmented filamentous bacteria.
Ivaylo I Ivanov, Koji Atarashi, Nicolas Manel, Eoin L Brodie, Tatsuichiro Shima, Ulas Karaoz, Dongguang Wei, Katherine C Goldfarb, Clark A Santee, Susan V Lynch,[...]. Cell 2009
4

Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD.
Yi Rang Na, Michelle Stakenborg, Seung Hyeok Seok, Gianluca Matteoli. Nat Rev Gastroenterol Hepatol 2019
159
4

Innate and adaptive immunity in inflammatory bowel disease.
Alessandra Geremia, Paolo Biancheri, Philip Allan, Gino R Corazza, Antonio Di Sabatino. Autoimmun Rev 2014
399
4

pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.
Ana Beloqui, Régis Coco, Patrick B Memvanga, Bernard Ucakar, Anne des Rieux, Véronique Préat. Int J Pharm 2014
107
4

Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
Bo Xiao, Zhigang Xu, Emilie Viennois, Yuchen Zhang, Zhan Zhang, Mingzhen Zhang, Moon Kwon Han, Yuejun Kang, Didier Merlin. Mol Ther 2017
67
5

Vedolizumab as induction and maintenance therapy for Crohn's disease.
William J Sandborn, Brian G Feagan, Paul Rutgeerts, Stephen Hanauer, Jean-Frédéric Colombel, Bruce E Sands, Milan Lukas, Richard N Fedorak, Scott Lee, Brian Bressler,[...]. N Engl J Med 2013
4

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome.
Israr Khan, Naeem Ullah, Lajia Zha, Yanrui Bai, Ashiq Khan, Tang Zhao, Tuanjie Che, Chunjiang Zhang. Pathogens 2019
141
4

Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis.
Philip Alex, Nicholas C Zachos, Thuan Nguyen, Liberty Gonzales, Tian-E Chen, Laurie S Conklin, Michael Centola, Xuhang Li. Inflamm Bowel Dis 2009
469
4


Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.
Nathaniel R West, Ahmed N Hegazy, Benjamin M J Owens, Samuel J Bullers, Bryan Linggi, Sofia Buonocore, Margherita Coccia, Dieter Görtz, Sébastien This, Krista Stockenhuber,[...]. Nat Med 2017
286
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.